Craneware (CRWRF) Stock Price, News & Analysis

Company Overview

Craneware plc is a healthcare technology company that develops software and services for hospitals and other healthcare providers. Its solutions are designed to help organizations manage revenue integrity, improve financial performance, support regulatory compliance, and make better use of clinical and financial data.

The company’s product portfolio includes the Trisus platform, which supports areas such as chargemaster management, pricing transparency, supply management, and revenue-cycle processes. Craneware also offers tools for medical-necessity assessment, audit and compliance, and the identification of potential revenue leakage or billing discrepancies.

Founded in 1999 and headquartered in Edinburgh, Scotland, Craneware has built a strong presence in the United States, where its software is used by healthcare providers and health systems. The company expanded its U.S. operations through the acquisition of Sentry Data Systems in 2021, adding further capabilities in revenue integrity and healthcare financial management.

Key Stats

• Today's Range: $18.00 to $18.00
• 50-Day Range: $15.23 to $19.00
• 52-Week Range: $15.23 to $19.00
• Volume: N/A
• Average Volume: 843 shs
• Market Capitalization: N/A
• P/E Ratio: 56.78
• Dividend Yield: 1.10%
• Price Target: N/A
• Consensus Rating: N/A

Craneware Stock Analysis - MarketRank™

Craneware scored higher than 29% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Craneware.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Craneware is 56.78, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 44.79.

Price to Earnings Ratio vs. Sector

The P/E ratio of Craneware is 56.78, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.01.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Craneware has a short interest ratio ("days to cover") of 7.76.

Change versus previous month

Short interest in Craneware has recently decreased by 77.06%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Craneware pays a meaningful dividend of 2.44%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Craneware does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Craneware is 62.40%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: N/A

News Sentiment

Craneware has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Craneware this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.6 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Craneware insiders have not sold or bought any company stock.

Percentage Held by Institutions

48.19% of the stock of Craneware is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: OTCMKTS:CRWRF
• CIK: N/A
• Web: www.craneware.com
• Phone: 441315503100
• Fax: N/A
• Employees: 747
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 56.78
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A